Outcome-driven analyses from contemporary cohorts suggest an association between ACE inhibitor or angiotensin receptor blocker therapy and improved survival in Takotsubo syndrome, particularly among patients with more severe left ventricular dysfunction or higher comorbidity burden [51]. Here, ACE is linked to Tako-tsubo cardiomyopathy.